We want to reveal new perspectives in cancer therapy.
Empowering Patients – Accelerating Science
Each year numerous new and promising substances in cancer medicine reach application maturity. Getting these drugs to official approval is a long, expensive process during which new therapies are not accessible to many patients. iuvando was founded to make innovative therapies available to all during the clinical trial phase and to shorten the time to official approval.
Who we are – get to know iuvando!
Dr. Mridul Agrawal and Dr. Benjamin Hanfstein can look back on many years of experience as physicians and scientists in cancer and leukemia research. They are united in their enthusiasm for targeted therapy approaches which have already brought immense improvements in certain areas of cancer treatment for patients. The development of these medicines prior to their official approval is a very expensive process that can take years, during which new therapies are not accessible to many patients. iuvando was founded to make innovative therapies available early in their clinical trial phase, and to shorten the time to official approval.
